DK1904504T3 - Inhibitorer af vegf-receptor- og hgf-receptorsignalering - Google Patents
Inhibitorer af vegf-receptor- og hgf-receptorsignaleringInfo
- Publication number
- DK1904504T3 DK1904504T3 DK06842339.1T DK06842339T DK1904504T3 DK 1904504 T3 DK1904504 T3 DK 1904504T3 DK 06842339 T DK06842339 T DK 06842339T DK 1904504 T3 DK1904504 T3 DK 1904504T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor
- hgf
- signal inhibitors
- vegf
- vegf receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68303805P | 2005-05-20 | 2005-05-20 | |
PCT/IB2006/003903 WO2007054831A2 (en) | 2005-05-20 | 2006-05-19 | Inhibitors of vegf receptor and hgf receptor signaling |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1904504T3 true DK1904504T3 (da) | 2014-06-23 |
Family
ID=38023642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06842339.1T DK1904504T3 (da) | 2005-05-20 | 2006-05-19 | Inhibitorer af vegf-receptor- og hgf-receptorsignalering |
Country Status (15)
Country | Link |
---|---|
US (2) | US7790729B2 (da) |
EP (1) | EP1904504B1 (da) |
JP (1) | JP5275792B2 (da) |
KR (1) | KR101078968B1 (da) |
CN (1) | CN101248080B (da) |
AU (1) | AU2006313456B2 (da) |
BR (1) | BRPI0610382A2 (da) |
CA (1) | CA2608726C (da) |
DK (1) | DK1904504T3 (da) |
ES (1) | ES2473341T3 (da) |
IL (1) | IL187422A0 (da) |
MX (1) | MX2007014617A (da) |
NZ (1) | NZ563774A (da) |
WO (1) | WO2007054831A2 (da) |
ZA (1) | ZA200709851B (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7202363B2 (en) | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
AU2005250285B2 (en) * | 2004-06-02 | 2011-08-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
KR101257343B1 (ko) * | 2004-07-30 | 2013-04-23 | 메틸진 인코포레이티드 | Vegf 수용체 및 hgf 수용체 신호전달 억제제 |
AU2006229343A1 (en) * | 2005-03-28 | 2006-10-05 | Kirin Pharma Kabushiki Kaisha | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency |
TW200806675A (en) * | 2006-01-30 | 2008-02-01 | Array Biopharma Inc | Heterobicyclic thiophene compounds and methods of use |
CA2655128A1 (en) * | 2006-06-08 | 2007-12-21 | Array Biopharma Inc. | Quinoline compounds and methods of use |
KR101435231B1 (ko) | 2006-08-24 | 2014-10-02 | 아스트라제네카 아베 | 증식성 질환의 치료에 유용한 모르폴리노 피리미딘 유도체 |
CN101809002B (zh) | 2007-07-09 | 2013-03-27 | 阿斯利康(瑞典)有限公司 | 用于与mtor激酶和/或pi3k相关的疾病中的吗啉代嘧啶衍生物 |
EP2183255A4 (en) | 2007-08-29 | 2011-06-15 | Methylgene Inc | METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF CONDENSED HETEROCYCLIC KINASE INHIBITORS |
CN105777776B (zh) | 2007-08-29 | 2021-06-08 | 梅特希尔基因公司 | 蛋白酪氨酸激酶活性的抑制剂 |
NZ589336A (en) * | 2008-03-05 | 2011-12-22 | Methylgene Inc | Pyridine derivatives as inhibitors of protein tyrosine kinase activity |
AU2009308853A1 (en) * | 2008-10-29 | 2010-05-06 | Deciphera Pharmaceuticals, Llc | Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
BRPI0921392A2 (pt) | 2008-12-05 | 2016-04-26 | Abbott Lab | inibidores quinase com perfil de segurança cyp aperfeiçoado |
US9340555B2 (en) | 2009-09-03 | 2016-05-17 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
RU2012109233A (ru) | 2009-09-03 | 2013-10-10 | Аллерган, Инк. | Соединения как модуляторы тирозинкиназы |
KR20130058006A (ko) * | 2010-04-16 | 2013-06-03 | 메틸진 인코포레이티드 | 단백질 티로신 키나아제 활성의 억제제 |
SA111320519B1 (ar) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | مركبات بيريميدينيل للاستخدام كمثبطات atr |
US8664244B2 (en) | 2010-09-12 | 2014-03-04 | Advenchen Pharmaceuticals, LLC | Compounds as c-Met kinase inhibitors |
US8697708B2 (en) | 2010-09-15 | 2014-04-15 | F. Hoffmann-La Roche Ag | Azabenzothiazole compounds, compositions and methods of use |
CN102153579B (zh) * | 2011-02-23 | 2013-05-29 | 兰州米诺生物科技有限公司 | 氮-叔丁氧羰基-1,2,5,6-四氢吡啶-4-硼酸频哪醇酯的合成方法 |
CN102827186A (zh) * | 2011-06-16 | 2012-12-19 | 中国科学院上海药物研究所 | 一类吡啶并五元杂环衍生物及其制备方法和用途 |
EP2729466B1 (en) | 2011-07-08 | 2015-08-19 | Novartis AG | Novel pyrrolo pyrimidine derivatives |
US8436179B2 (en) | 2011-07-20 | 2013-05-07 | Abbvie Inc. | Kinase inhibitor with improved solubility profile |
CN104220058A (zh) | 2012-01-27 | 2014-12-17 | 国立大学法人富山大学 | 丝氨酸消旋酶抑制剂 |
GB2499666A (en) * | 2012-02-27 | 2013-08-28 | Nanyang Polytechnic | Mcl-1 inhibitors for the treatment of conditions associated with proliferative disorders |
CN104507930B (zh) * | 2012-06-29 | 2017-10-10 | 贝达药业股份有限公司 | 作为c‑Met酪氨酸激酶抑制剂的新型稠合吡啶衍生物 |
TWI520962B (zh) * | 2012-06-29 | 2016-02-11 | As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives | |
US9925193B2 (en) | 2012-11-20 | 2018-03-27 | Proqinase Gmbh | Thioether derivatives as protein kinase inhibitors |
CN103396417B (zh) * | 2013-08-14 | 2015-02-04 | 冯子侠 | 新型羟肟酸衍生物及其医疗应用 |
CN106995452B (zh) * | 2016-12-22 | 2018-03-16 | 湖北民族学院 | 一种噻吩并[3,2‑d]嘧啶类EGFR/ErbB2双靶点抑制剂及其制备方法和用途 |
CN113874015B (zh) | 2018-12-21 | 2024-05-24 | 细胞基因公司 | Ripk2的噻吩并吡啶抑制剂 |
US10702525B1 (en) | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
KR100446363B1 (ko) | 1997-11-11 | 2004-09-01 | 화이자 프로덕츠 인코포레이티드 | 항암제로 유용한 티에노피리미딘 및 티에노피리딘 유도체 |
PL345906A1 (en) | 1998-06-04 | 2002-01-14 | Abbott Lab | Cell adhesion-inhibiting antinflammatory compounds |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
WO2000075145A1 (en) | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
MXPA02012034A (es) | 2000-06-06 | 2003-04-25 | Pfizer Prod Inc | Derivados de tiofeno utiles como agentes anticancerosos. |
US20020004511A1 (en) | 2000-06-28 | 2002-01-10 | Luzzio Michael Joseph | Thiophene derivatives useful as anticancer agents |
US6488261B1 (en) * | 2001-02-21 | 2002-12-03 | Jen-Chieh Lee | Ball valve |
GB0115109D0 (en) | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
AU2002345792A1 (en) | 2001-06-21 | 2003-01-08 | Pfizer Inc. | Thienopyridine and thienopyrimidine anticancer agents |
CA2454538A1 (en) * | 2001-06-22 | 2003-01-03 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
EP1483268A2 (en) | 2002-03-01 | 2004-12-08 | Pfizer Inc. | Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents |
US20030199525A1 (en) * | 2002-03-21 | 2003-10-23 | Hirst Gavin C. | Kinase inhibitors |
CL2003002287A1 (es) | 2002-11-25 | 2005-01-14 | Wyeth Corp | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS |
JP2007504122A (ja) | 2003-08-29 | 2007-03-01 | ファイザー・インク | 新規抗血管形成剤として有用なチエノピリジン−フェニルアセトアミドおよびその誘導体 |
WO2005052872A1 (en) | 2003-11-21 | 2005-06-09 | Facil, Llc | Financial transaction system and method |
EP1711495A2 (en) | 2004-01-23 | 2006-10-18 | Amgen Inc. | Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
WO2005121125A1 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Inc. | Ether-linked heteroaryl compounds |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
CA2572331A1 (en) * | 2004-07-02 | 2006-02-09 | Exelixis, Inc. | C-met modulators and method of use |
WO2006036266A1 (en) | 2004-07-16 | 2006-04-06 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as aurora kinase inhibitors |
KR101257343B1 (ko) * | 2004-07-30 | 2013-04-23 | 메틸진 인코포레이티드 | Vegf 수용체 및 hgf 수용체 신호전달 억제제 |
AU2006229343A1 (en) * | 2005-03-28 | 2006-10-05 | Kirin Pharma Kabushiki Kaisha | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency |
JO2787B1 (en) | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
JP5148499B2 (ja) | 2005-05-20 | 2013-02-20 | メチルジーン インコーポレイテッド | Vegf受容体およびhgf受容体シグナル伝達の阻害剤 |
TW200806675A (en) | 2006-01-30 | 2008-02-01 | Array Biopharma Inc | Heterobicyclic thiophene compounds and methods of use |
-
2006
- 2006-05-19 CN CN2006800264982A patent/CN101248080B/zh not_active Expired - Fee Related
- 2006-05-19 WO PCT/IB2006/003903 patent/WO2007054831A2/en active Application Filing
- 2006-05-19 EP EP06842339.1A patent/EP1904504B1/en not_active Not-in-force
- 2006-05-19 CA CA2608726A patent/CA2608726C/en not_active Expired - Fee Related
- 2006-05-19 ES ES06842339.1T patent/ES2473341T3/es active Active
- 2006-05-19 BR BRPI0610382-0A patent/BRPI0610382A2/pt not_active IP Right Cessation
- 2006-05-19 NZ NZ563774A patent/NZ563774A/xx not_active IP Right Cessation
- 2006-05-19 JP JP2008511825A patent/JP5275792B2/ja not_active Expired - Fee Related
- 2006-05-19 AU AU2006313456A patent/AU2006313456B2/en not_active Ceased
- 2006-05-19 US US11/419,353 patent/US7790729B2/en active Active
- 2006-05-19 KR KR1020077029762A patent/KR101078968B1/ko active IP Right Grant
- 2006-05-19 DK DK06842339.1T patent/DK1904504T3/da active
- 2006-05-19 MX MX2007014617A patent/MX2007014617A/es active IP Right Grant
-
2007
- 2007-11-15 ZA ZA200709851A patent/ZA200709851B/xx unknown
- 2007-11-15 IL IL187422A patent/IL187422A0/en unknown
-
2010
- 2010-03-25 US US12/731,328 patent/US20100249145A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0610382A2 (pt) | 2010-06-15 |
CN101248080B (zh) | 2012-09-05 |
EP1904504A2 (en) | 2008-04-02 |
CA2608726C (en) | 2013-07-09 |
IL187422A0 (en) | 2008-02-09 |
KR20080027782A (ko) | 2008-03-28 |
AU2006313456A1 (en) | 2007-05-18 |
EP1904504A4 (en) | 2010-06-02 |
US20060287343A1 (en) | 2006-12-21 |
JP2008540639A (ja) | 2008-11-20 |
US7790729B2 (en) | 2010-09-07 |
ES2473341T3 (es) | 2014-07-04 |
CN101248080A (zh) | 2008-08-20 |
AU2006313456B2 (en) | 2011-06-23 |
CA2608726A1 (en) | 2007-05-18 |
WO2007054831A2 (en) | 2007-05-18 |
KR101078968B1 (ko) | 2011-11-01 |
MX2007014617A (es) | 2008-02-11 |
NZ563774A (en) | 2010-04-30 |
WO2007054831A3 (en) | 2007-10-04 |
ZA200709851B (en) | 2009-08-26 |
US20100249145A1 (en) | 2010-09-30 |
EP1904504B1 (en) | 2014-03-19 |
JP5275792B2 (ja) | 2013-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1904504T3 (da) | Inhibitorer af vegf-receptor- og hgf-receptorsignalering | |
IL187484A0 (en) | Inhibitors of vegf receptor and hgf receptor signaling | |
DE602005002517D1 (de) | Drehtisch | |
DE602005001672D1 (de) | Durchmesser Messgeräte | |
ATE382619T1 (de) | 4-hydroxy-4-methylpiperidin-1-carbonsäure-(4- methoxy-7-morpholin-4-ylbenzothiazol-2-yl)-amid | |
DE602005012730D1 (de) | Lk-kommunikationsgerät | |
DE602005016187D1 (de) | Staubreduzierende Einrichtung | |
DE602005021211D1 (de) | Befestigungsvorrichtung | |
DK1789800T3 (da) | Ileitis-diagnosetest | |
DE602004025215D1 (de) | Tastsonde | |
DE502005006735D1 (de) | Stelleinrichtung | |
DK1784181T3 (da) | VEGF-hæmning | |
DE602005017079D1 (de) | Signalroutingvorrichtung und Signalroutingprogramm | |
DE602005003573D1 (de) | Jitter-messung | |
DE502005000300D1 (de) | Tastkopf | |
ITMI20062284A1 (it) | Termofusibile | |
DE602006020111D1 (de) | Siebvorrichtung | |
FI20055133A0 (fi) | Iskulaite | |
SE0601732L (sv) | Sättanordning | |
DE102004022911A8 (de) | Signalabtastung | |
DE602005012509D1 (de) | Kegelspielvorrichtung | |
DE502006001770D1 (de) | Befestigungsvorrichtung | |
DE602005005256D1 (de) | Siebvorrichtung | |
ATE454934T1 (de) | Drehteller | |
ITMI20040472A1 (it) | Dispositivo disidratante |